CGRP migraine prophylaxis available on private script

The CGRP-targeted migraine prophylaxis treatment galcanezumab (Emgality) is being made available on private prescription for under $300 a month while it awaits PBS listing, according to Eli Lilly. Via the manufacturer’s Ember program neurologists will be able to prescribe the first two monthly subcutaneous injections of galcanezumab free for enrolled patients from October 2019, and ...

Already a member?

Login to keep reading.

© 2021 the limbic